NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Basgenbio

Basgenbio

Private
SeoulHealthcare & Life Scienceshttps://basgenbio.com/kr/

Last Round

VC Round

Dec 22, 2025

Total Funding Raised

$13.29M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Basgenbio is a biotechnology company that provides biomarker discovery and AI-driven drug development platforms by analyzing clinico-genomic cohort data.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS, Government Contracts, Revenue Share

AI Layer

Application

Keywords

drug discoveryclinical trial simulationbiomarker discoveryin silicoprecision medicineclinico-genomic databaseAI drug discoverypatient stratificationdrug response predictionSaaSbiotech AIdigital twintarget discoverypharma tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Basgenbio Comparables

Compare Basgenbio with similar companies based on industry and business-model similarity.

Basgenbio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
VeriSIM Life
87%
QuantHealth
84%
PharmCADD Co., Ltd.
83%

Basgenbio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundDec 22, 2025
GrantDec 22, 2025
GrantAug 21, 2025
Series BJun 8, 2023
Series AMay 28, 2021
Strategic
May 24, 2021

Key People

Founding team and executive leadership

Yunsu Yang

COO co-founder

Founding Team

Basgenbio Investors

Notable investors and investment history

Basgenbio investors
InvestorRounds
DS Asset ManagementSeries A
Pathfinder HVC Round
CelltrionSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2025

    $3.31M raised in grant funding.

  • Jun 1, 2025

    Monthly visitors grew 60% MoM, reaching 1.6K.

Basgenbio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Basgenbio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Basgenbio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul
Employee Range21
Year Founded2018
Last FundingDec 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.